High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
760.49M
+4.24%
1.550
+9.17%
682.02M
+2.6%
1.125
+11.38%
737.16M
+2.34%
1.322
+12.01%
Estimates Revision
The market is revising Downward the revenue expectations for Revvity, Inc. (RVTY) for FY2025, with the revenue forecasts being adjusted by -0.22% over the past three months. During the same period, the stock price has changed by 18.36%.
Revenue Estimates for FY2025
Revise Downward
-0.22%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+0.91%
In Past 3 Month
Stock Price
Go Up
+18.36%
In Past 3 Month
11 Analyst Rating
Wall Street analysts forecast RVTY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RVTY is 111.10 USD with a low forecast of 100.00 USD and a high forecast of 125.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Buy
3 Hold
0 Sell
Moderate Buy
Current: 102.550
Low
100.00
Averages
111.10
High
125.00
Current: 102.550
Low
100.00
Averages
111.10
High
125.00
BofA
Buy
upgrade
$99 -> $105
2025-10-28
Reason
BofA
Price Target
$99 -> $105
2025-10-28
upgrade
Buy
Reason
BofA raised the firm's price target on Revvity to $105 from $99 and keeps a Buy rating on the shares. Despite Q3 being "a straightforward print," it sets up for a steep Q4 sales and operating margin ramp that the firm views as "achievable," though some risk remains, the analyst tells investors.
Barclays
Overweight
maintain
$100 -> $105
2025-10-28
Reason
Barclays
Price Target
$100 -> $105
2025-10-28
maintain
Overweight
Reason
Barclays raised the firm's price target on Revvity to $105 from $100 and keeps an Overweight rating on the shares post the Q3 report. The firm views the quarter as "mixed" but says the step-up embedded in the Q4 guidance "seems more achievable."
Baird
Outperform
maintain
$122 -> $123
2025-10-28
Reason
Baird
Price Target
$122 -> $123
2025-10-28
maintain
Outperform
Reason
Baird raised the firm's price target on Revvity to $123 from $122 and keeps an Outperform rating on the shares. The firm updated its model and noted a muted response from the market to its in-line update.
Evercore ISI
Outperform
maintain
$106 -> $108
2025-10-27
Reason
Evercore ISI
Price Target
$106 -> $108
2025-10-27
maintain
Outperform
Reason
Evercore ISI raised the firm's price target on Revvity to $108 from $106 and keeps an Outperform rating on the shares. Q3 organic growth of 1% was inline with the Street and EPS of $1.18 beat the Street estimate while FY25 EPS guidance was raised by 5c to $4.90-$5.00, the analyst tells investors.
Baird
Catherine Ramsey Schulte
Outperform
maintain
$121 -> $122
2025-10-24
Reason
Baird
Catherine Ramsey Schulte
Price Target
$121 -> $122
2025-10-24
maintain
Outperform
Reason
Baird analyst Catherine Ramsey Schulte raised the firm's price target on Revvity to $122 from $121 and keeps an Outperform rating on the shares. The firm updated its model ahead of its Q3 results.
Guggenheim
Neutral
initiated
2025-10-16
Reason
Guggenheim
Price Target
2025-10-16
initiated
Neutral
Reason
Guggenheim last night initiated coverage of Revvity with a Neutral rating and no price target. While the stock's valuation screens attractively, Revvity is facing a host of company-specific challenges; while these are transitory and is unlikely to outperform peers in the near-term, the analyst tells investors in a research note. The firm believes Revvity's organic revenue growth expectations for 2026 are likely too high due to China reimbursement challenges and difficult comparisons.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Revvity Inc (RVTY.N) is 19.50, compared to its 5-year average forward P/E of 21.98. For a more detailed relative valuation and DCF analysis to assess Revvity Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Fair
5Y Average PE
21.98
Current PE
19.50
Overvalued PE
25.67
Undervalued PE
18.29
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
17.57
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
20.61
Undervalued EV/EBITDA
14.53
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
4.58
Current PS
0.00
Overvalued PS
5.29
Undervalued PS
3.87
Financials
Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
RVTY News & Events
Events Timeline
(ET)
2025-11-10
08:09:07
Revvity to Purchase ACD/Labs, Financial Details Not Revealed
2025-10-27 (ET)
2025-10-27
06:06:18
Revvity increases 2025 adjusted EPS forecast to $4.90-$5.00, up from $4.85-$4.95
2025-10-27
06:02:28
Revvity announces Q3 adjusted EPS of $1.18, surpassing consensus of $1.14
Sign Up For More Events
Sign Up For More Events
News
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/12d442e2ba8d43528b08f5f9d1febdf468f76a949f0ff7fb69704a07c5f1fff0.jpg)
Preview
8.0
11-20NASDAQ.COMRVTY Options for January 2026 Now Available for Trading
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/dfbd5b64ee73c45c4ac714cc682cbf9b7f27500dc2a53377d6f52a1b50ef0c3c.png)
Preview
4.5
11-10Yahoo FinanceMarket Update: Health Care Stocks Show Varied Performance in Monday's Premarket Trading
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/default_image/newsfilter.png)
Preview
8.5
11-10NewsfilterRevvity to Purchase ACD/Labs to Enhance Signals Software Features
Sign Up For More News
People Also Watch
FAQ
What is Revvity Inc (RVTY) stock price today?
What is Revvity Inc (RVTY)'s business?
What is the price predicton of RVTY Stock?
What is Revvity Inc (RVTY)'s revenue for the last quarter?
What is Revvity Inc (RVTY)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Revvity Inc (RVTY)'s fundamentals?
How many employees does Revvity Inc (RVTY). have?